PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 257 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615,261 | -35.4% | 73,684 | -0.2% | 0.12% | -32.0% |
| Q2 2023 | $951,875 | +17.0% | 73,846 | -0.5% | 0.18% | +6.5% |
| Q1 2023 | $813,659 | +35.4% | 74,239 | +1.0% | 0.17% | +23.2% |
| Q4 2022 | $601,058 | +25.2% | 73,479 | -11.1% | 0.14% | +11.3% |
| Q3 2022 | $480,000 | +45.5% | 82,662 | +10.8% | 0.12% | +49.4% |
| Q2 2022 | $330,000 | -52.4% | 74,573 | +1.7% | 0.08% | -46.1% |
| Q1 2022 | $693,000 | -52.9% | 73,295 | +2.0% | 0.15% | -54.2% |
| Q4 2021 | $1,470,000 | -21.2% | 71,837 | -1.7% | 0.34% | -23.6% |
| Q3 2021 | $1,866,000 | -26.6% | 73,046 | +0.4% | 0.44% | -30.9% |
| Q2 2021 | $2,543,000 | +10.4% | 72,720 | +3.7% | 0.64% | +4.1% |
| Q1 2021 | $2,304,000 | -2.0% | 70,132 | +9.4% | 0.61% | +13.1% |
| Q4 2020 | $2,352,000 | +317.0% | 64,100 | +12.3% | 0.54% | +258.3% |
| Q3 2020 | $564,000 | – | 57,100 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |